By Chris Wack


Sonoma Pharmaceuticals Inc. shares were up 82% at $2.18 after the company said that its Microcyn Rx products have received a distribution and pricing agreement from the Defense Logistics Agency.

The company said the pricing agreement enables its partner, EMC Pharma, to enter into distribution agreements for Microcyn Rx products with federal customers.

About half of EMC Pharma's customers are U.S. government entities, including VA hospitals, the Department of Defense, the Federal Bureau of Prisons, as well as state and local prison systems. EMC Pharma is a 100% minority-owned and a certified Minority Business Enterprise.

The distribution and pricing agreement approval process was a coordinated effort by Sonoma and EMC Pharma for Sonoma's Microcyn Rx products, including wound care, prescription dermatology products, Celacyn and Levicyn, as well as prescription eye care Acuicyn.

Sonoma stock hit its 52-week low of $1 on Dec. 28, and is down 36% in the past twelve months.


Write to Chris Wack at chris.wack@wsj.com


(END) Dow Jones Newswires

01-25-23 1046ET